LUNG
Pulmonx Corporation
Medical Devices · Healthcare · United States
3.01
close · 2026-10-30
value
12
cheaper than peers12
quality
5
stronger fundamentals5
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 1.48× | 71 |
| price to book | 3.79× | 41 |
| earnings yield, 3 years ago | -52.9% | 25 |
| earnings yield, 1 year ago | -47.9% | 24 |
| earnings yield, 2 years ago | -53.2% | 23 |
| cash flow yield, 1 year ago | -25.6% | 21 |
| earnings yield, latest year | -44.3% | 20 |
| cash flow yield, 3 years ago | -36.0% | 20 |
| cash flow yield, latest year | -25.4% | 20 |
| cash flow yield, 2 years ago | -29.8% | 19 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | -39.8% | 25 |
| return on equity | -88.9% | 22 |
| debt to equity | 143.4% | 21 |
| revenue growth | -4.6% | 12 |
4 of 4 measures available
Facts
| market cap | $129M |
| free cash flow | -$11.7M |
| employees | 296 |
| first trade | 2020-10-01 |
| next earnings | 2026-10-27 |
| fundamentals updated | 2026-10-27 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -1.33 | -1.44 | -1.60 | -1.59 |
| free cash flow | -$32.8M | -$33.0M | -$38.4M | -$46.4M |
| net income | -$54.0M | -$56.4M | -$60.8M | -$58.9M |
| revenue | $90.5M | $83.8M | $68.7M | $53.7M |